Underwriting D&O for Newly Listed Indian Companies in 2026: The Post-IPO Step-Change in Exposure

A directors-and-officers (D&O) liability programme that was adequate for a private company is rarely adequate for the same company once it lists, because listing changes the nature of the risk rather than just its size. As a private company, the D&O exposure comes mainly from regulators, employees, lenders, counterparties and a small, known group of shareholders, and the board's actions are scrutinised by a closed circle. The moment the shares are offered to the public and admitted to trading, a new and far larger set of claimants and a new body of law attach to the directors and officers, and the exposure steps up rather than scales up.

Three things change at once. First, the prospectus, the offer document through which the company raises money from the public, becomes a source of liability: statements in it must be true and not misleading, and investors who subscribe can claim against the company and its directors if they were not. Second, the shareholder base becomes public and dispersed, so a fall in the share price can turn a large number of investors into potential claimants alleging that disclosure was deficient, a category of claim that simply did not exist when the company was private. Third, the company comes under the continuous-disclosure and governance regime that applies to listed entities, and the regulator's enforcement reach over the board widens considerably. Each of these is a distinct exposure, and together they make the post-IPO D&O risk qualitatively different.

This post sets out how D&O is underwritten and structured for a newly listed Indian company in 2026: the IPO and prospectus liability the offering creates, the SEBI LODR and enforcement regime that drives the ongoing risk, the securities-litigation and shareholder exposure that listing opens, how capacity and pricing behave for fresh listings, and the governance signals an underwriter reads before taking the risk.

The offering itself is the first new exposure, and it has its own structure in the D&O market. When a company makes an initial public offering, the directors and the company make representations in the offer document (the draft red herring prospectus and the prospectus), and Indian law imposes liability for misstatements and omissions in that document. The relevant provisions sit across the Companies Act 2013 (civil and criminal liability for misstatements in a prospectus) and the SEBI framework governing public issues, and the people exposed include the directors, the promoters, and those who authorised the issue of the prospectus. A claim that the prospectus was untrue or misleading, brought by investors who subscribed on the strength of it, is the signature IPO D&O exposure.

IPO extensions and dedicated POSI

The market addresses this in two ways. A standard listed-company D&O policy may include an IPO extension that brings the offering within cover, often with conditions and a sub-limit. For a larger or higher-profile offering, the more deliberate route is a dedicated public offering of securities insurance (POSI) policy, a standalone cover written specifically for the offering. POSI is purchased for the transaction, responds to claims arising from the prospectus and the offer, and is typically written for a multi-year period (commonly six or seven years) on a single, ring-fenced limit dedicated to the offering, so that prospectus claims do not erode the ongoing D&O limit the directors need for everything else.

The logic for separating POSI from the run-rate D&O programme is sound. Prospectus liability has a long tail, claims can surface years after the offering as the company's later performance is read back against what the prospectus said, and a single dedicated limit for the offering protects both the directors (who get a limit reserved for the transaction) and the ongoing programme (which is not consumed by an offering claim). An underwriter pricing the offering looks closely at the quality of the offer document and the diligence behind it, the use of proceeds, the financial forecasts and risk factors disclosed, the reputation of the lead managers and the legal and accounting advisers, and the realism of the valuation, because an aggressively priced offering on optimistic disclosure is the profile most likely to generate a prospectus claim if the share price disappoints. The cleaner the diligence and the more conservative the disclosure, the more comfortable the offering underwriting, and the structure (extension versus standalone POSI, the period, the dedicated limit) follows from the size and profile of the issue.

After the offering, the newly listed company lives under the continuous obligations of a listed entity, and that regime is the main driver of the ongoing post-IPO D&O risk. The central instrument is the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR), which sets the disclosure, governance and compliance duties of listed companies and their boards, alongside the SEBI Act and the prohibitions on insider trading and fraudulent and unfair trade practices.

What LODR adds to the board's exposure

LODR imposes continuous obligations that did not bind the company as a private entity: timely disclosure of material events and price-sensitive information, periodic financial reporting, board composition and independent-director requirements, audit-committee and related-party-transaction governance, and a stream of certifications and filings. A failure in any of these, a delayed or selective disclosure, a related-party transaction that was not properly approved or disclosed, a governance lapse, becomes a potential basis for SEBI action against the company and, importantly for D&O, against the directors and officers personally. The continuous-disclosure regime means the board is making consequential disclosure decisions constantly, and each is a point at which liability can arise.

SEBI enforcement reaching the board

SEBI's enforcement powers reach the individuals on the board, and that personal reach is what makes LODR a D&O issue rather than only a corporate-compliance issue. SEBI can investigate, issue show-cause notices, pass orders imposing monetary penalties, disgorgement and debarment, and pursue adjudication and settlement, and these can be directed at directors and key managerial personnel individually. The defence costs of responding to a SEBI investigation or proceeding, which can run for years and involve substantial legal and forensic work, are themselves a major part of the D&O exposure, often before any penalty is determined. A well-structured listed-company D&O policy responds to the costs of these investigations and proceedings (subject to the treatment of fines and penalties, which are generally not insurable where they are penal), and the underwriter pricing the risk weighs the company's disclosure discipline, the strength of its compliance and secretarial function, and its history of regulatory interaction.

The newly listed company is in the period of highest LODR risk precisely because it is new to the regime: its processes for material-event disclosure, insider-trading compliance and related-party governance are freshly built and not yet seasoned, and the gap between the discipline a public company requires and the habits carried over from private life is widest in the first years after listing. Underwriters read the first-year-listed company as carrying elevated compliance-execution risk for exactly this reason, and the governance signals discussed later are largely about whether that gap has been closed.

The most distinctive post-IPO exposure is the claim brought by public shareholders, and although the Indian securities-litigation environment is less developed than the United States, the exposure is real and growing, and it is the exposure that listed-company D&O cover exists to address.

The Indian shareholder-claim environment

India does not have the mature securities-class-action machinery of the US federal courts, but it has several routes through which dispersed shareholders can pursue directors. The Companies Act 2013 provides for class action by members and depositors under section 245, allowing a defined group of shareholders to bring proceedings against the company, its directors, auditors and others for conduct prejudicial to their interests. The National Company Law Tribunal hears oppression-and-mismanagement and class-action matters. SEBI proceedings, while regulatory rather than shareholder-driven, frequently run alongside or trigger investor grievances. And as Indian capital markets deepen, the volume of retail and institutional investors holding listed shares, and their willingness to organise and litigate when disclosure proves deficient and the price falls, has been rising. The exposure is not hypothetical: a company that lists, disappoints, and is found to have disclosed poorly faces both SEBI action and the prospect of shareholder claims, and the directors are named in both.

Why listing creates the exposure

The mechanism is the same one that operates in more litigious markets. Public, dispersed ownership means a large number of investors hold the shares; a fall in the share price creates a class of investors who have lost money; and if that fall can be linked to a misstatement in the prospectus or to deficient continuous disclosure, those investors have a grievance against the directors who were responsible for the disclosure. The private company had none of this because its shares were not publicly held or traded. Listing creates the claimant class and the price signal that mobilises it, and the prospectus and the LODR disclosure stream provide the documents against which the company's statements are tested. For the D&O underwriter this is the catastrophe scenario the limit is sized against: a failed or disappointing listing followed by regulatory action and shareholder claims, with defence costs and potential settlements falling on the directors and the policy. The structure of the cover (the IPO or POSI treatment for prospectus claims, the listed-company D&O for ongoing securities and regulatory exposure, and adequate limits sized to a real multi-party scenario rather than a token figure) is built around this possibility.

Pricing and capacity for newly listed D&O behave differently from established-listed or private-company D&O, because the fresh listing carries the prospectus exposure, the unseasoned compliance environment and the absence of a public-market track record all at once, and the market prices that combination accordingly.

Why fresh listings price higher

A newly listed company is, from the underwriter's view, an account with new and untested exposure. The prospectus liability is at its freshest, the LODR compliance processes are new, there is no history of how the board handles continuous disclosure under public scrutiny, and the share price (the trigger for shareholder claims) is unproven and can be volatile in the early period after listing. The underwriter has less to go on than for a company with years of public-market behaviour to read, so the uncertainty premium is higher. The pricing also reflects the offering's own characteristics: the size of the raise, the valuation and how aggressive it is, the sector (some sectors attract more disclosure scrutiny and price volatility than others), the use of proceeds, and the quality of the offer document and the diligence behind it. An aggressively valued offering in a scrutinised sector on optimistic disclosure prices very differently from a conservatively priced offering with clean diligence in a stable sector.

Capacity, layering and conditions

For the limits a sizeable listing needs, the cover is usually built as a tower: a primary D&O layer and excess layers above it, often with several insurers participating, because few single insurers will deploy the whole limit on a fresh listing. The newly listed account frequently attracts conditions: a dedicated or sub-limited treatment of the IPO exposure, specific attention to the prospectus and the offering in the wording, and sometimes warranties or exclusions around known issues disclosed in diligence. Side-A cover (protecting individual directors where the company cannot indemnify them, for example in insolvency or where indemnification is barred) matters especially for a listed company, because the directors' personal exposure is the point of the cover, and a well-structured tower preserves a Side-A limit for the individuals.

The practical reading for a company approaching its IPO is that the D&O programme should be designed alongside the offering, not bought as an afterthought at listing. The offering underwriting (the offer document, the diligence, the valuation, the advisers) feeds directly into the D&O underwriting, the structure has to separate the prospectus exposure from the ongoing programme, and the limits have to be sized to a genuine multi-party regulatory-and-shareholder scenario. Engaging the D&O market early, with a clean diligence story and a clear governance picture, is what secures capacity on reasonable terms; arriving late with an aggressive valuation and a thin governance narrative is what produces high pricing, tight conditions or constrained capacity.

Because the newly listed company has little public-market track record, the underwriter relies heavily on governance signals as the proxy for how the board will handle the disclosure and compliance obligations that drive the claims. Governance quality is the single most important underwriting input for a fresh listing, and the underwriter reads it across several dimensions.

Board composition and independence

The underwriter looks at the board: the proportion and calibre of independent directors, the separation of chair and chief executive where it exists, the experience of the directors in running or governing a listed company, and whether the board has the independence to challenge management. A board dominated by promoters with few genuinely independent voices, or independent directors who lack the standing or information to challenge, is a weaker governance signal than a balanced, experienced board. The functioning of the key committees (audit, nomination and remuneration, risk, stakeholder relationship) and whether they meet, have proper terms of reference and actually exercise oversight, is read as evidence of governance substance rather than form.

Disclosure discipline and the compliance function

The underwriter assesses the company's readiness for continuous disclosure under LODR: the strength of the company-secretarial and compliance function, the processes for identifying and disclosing material events and price-sensitive information promptly, the insider-trading code and its enforcement, and the governance around related-party transactions, which are a frequent source of both SEBI action and shareholder grievance. A company that has invested in a capable compliance function and built real disclosure processes ahead of listing presents a materially better risk than one treating LODR as a box-ticking exercise.

Financial reporting, audit and the diligence story

The quality and independence of the audit, the company's accounting practices, the realism of the financial reporting, and any history of restatements or audit qualifications are read closely, because financial-reporting failure is a common root of securities claims. The diligence done for the offering, the quality of the advisers, and the conservatism of the disclosure all feed the same judgement. The underwriter is, in effect, forming a view on the probability that the company will disclose well, comply with LODR, report its finances honestly, and govern itself with the independence a listed company requires, and the governance signals are the evidence for that view. A company that wants D&O on reasonable terms for its listing should be able to tell a credible governance story, supported by a real board, a real compliance function and clean diligence, because that story is what the underwriting turns on.

Underwriting D&O for a newly listed Indian company is the underwriting of a step-change, and the programme has to be built for the new exposures rather than scaled up from the private-company cover. Listing brings prospectus liability through the offer document, a public and dispersed shareholder base that can become a claimant class, the continuous-disclosure and governance obligations of SEBI LODR, and the personal reach of SEBI enforcement over the board. Each is a distinct exposure, and the D&O structure has to address each: an IPO extension or dedicated POSI for the offering, with its own long-tail dedicated limit; a listed-company D&O programme for the ongoing securities and regulatory risk; adequate limits and a sensible tower sized to a real multi-party scenario; and Side-A protection for the individual directors.

For the company and the broker, the work is to engage the D&O market early and alongside the offering, to present a clean diligence and governance story, and to separate the prospectus exposure from the run-rate programme so neither erodes the other. For the underwriter, the work is to price the fresh listing's untested exposure off the offering's characteristics and the company's governance signals, because those signals are the best available proxy for how the board will handle the disclosure and compliance that generate claims. The newly listed company is in its period of highest D&O risk in the first years after listing, when its compliance processes are new and its public-market behaviour is unproven, and the programme and the governance both need to be ready before the bell rings.

Getting the structure right depends on knowing exactly how each insurer's listed-company D&O and POSI wordings treat prospectus liability, IPO extensions, SEBI investigation costs, the insurability of penalties, and the Side-A protections that matter to individual directors. Those terms differ across the market and decide what the directors actually recover when a claim comes. Sarvada gives commercial insurance brokers structured, searchable access to insurer D&O and POSI policy wordings, so the offering treatment, the investigation-cost grants, the exclusions and the Side-A terms can be compared across insurers and matched to a newly listed company's real exposure. Request Access to ground post-IPO D&O structuring in the wording detail that decides what the board is actually covered for.